A malaria drug widely touted by President Donald Trump for dealing with the new coronavirus revealed no benefit in a large analysis of its usage in U.S. veterans health centers. There were more deaths amongst those offered hydroxychloroquine versus standard care, scientists reported.
The nationwide research study was not a rigorous experiment. With 368 patients, it’s the largest appearance so far of hydroxychloroquine with or without the antibiotic azithromycin for COVID-19, which has actually eliminated more than 171,000 individuals as of Tuesday.
The research study was posted on an online website for researchers and has not been reviewed by other scientists. Grants from the National Institutes of Health and the University of Virginia paid for the work.
Researchers analyzed medical records of 368 male veterans hospitalized with confirmed coronavirus infection at Veterans Health Administration medic